KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) Net Margin (2017 - 2025)

Twist Bioscience (TWST) has disclosed Net Margin for 9 consecutive years, with 29.42% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 619.0% to 29.42% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 19.56% through Dec 2025, up 4018.0% year-over-year, with the annual reading at 20.63% for FY2025, 4608.0% up from the prior year.
  • Net Margin for Q4 2025 was 29.42% at Twist Bioscience, down from 27.41% in the prior quarter.
  • The five-year high for Net Margin was 21.23% in Q2 2025, with the low at 126.06% in Q1 2022.
  • Average Net Margin over 5 years is 74.54%, with a median of 83.15% recorded in 2022.
  • The sharpest move saw Net Margin crashed -3371bps in 2021, then skyrocketed 12627bps in 2025.
  • Over 5 years, Net Margin stood at 108.44% in 2021, then rose by 29bps to 77.1% in 2022, then increased by 22bps to 60.15% in 2023, then soared by 41bps to 35.61% in 2024, then grew by 17bps to 29.42% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 29.42%, 27.41%, and 21.23% for Q4 2025, Q3 2025, and Q2 2025 respectively.